Concourse Financial Group Securities’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 7690 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 8051 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 8047 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 8050 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 8052 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 7986 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 7789 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 7596 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 7330 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 7342 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 7164 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 7074 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 6937 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 6838 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 6617 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 6382 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 6163 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 5969 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 5754 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 5601 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 5539 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 5453 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 5291 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 5360 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 5273 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5173 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 4985 |
|